Skip to main content
. Author manuscript; available in PMC: 2018 Dec 5.
Published in final edited form as: Sci Transl Med. 2011 Aug 10;3(95):95ra74. doi: 10.1126/scitranslmed.3002530

Fig. 2.

Fig. 2.

Antitumor effect of curaxin CBLC137 in xenograft mouse models of cancer. (A to D) Renal cell carcinoma Caki-1 (A), colon carcinoma DLD-1 (B), melanoma Mel-7 (C), and pancreatic ductal adeno-carcinoma (PDA) (D). Data are mean fold change in tumor volume (5 to 10 mice per group) relative to day 1 of treatment ± SD. *P < 0.005 for comparison of CBLC137 and vehicle, analysis of variance (ANOVA) test. See also fig. S2.